Related references
Note: Only part of the references are listed.A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
Ji-Youn Han et al.
CLINICAL CANCER RESEARCH (2011)
EFFECTS OF BUDESONIDE ON P38 MAPK ACTIVATION, APOPTOSIS AND IL-8 SECRETION, INDUCED BY TNF-α AND HAEMOPHILUS INFLUENZAE IN HJMAN BRONCHIAL EPITHELIAL CELLS
L. Gallelli et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2010)
Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations
In Hae Park et al.
INVESTIGATIONAL NEW DRUGS (2010)
Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era
Grzegorz S. Nowakowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Update on nonsmall cell lung cancer
G. Zalcman et al.
EUROPEAN RESPIRATORY REVIEW (2010)
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-β-induced proliferation of human lung fibroblasts
L. Gallelli et al.
CELL PROLIFERATION (2008)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets
Panagiotis A. Konstantinopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer
Xiaozhu Zhang et al.
JOURNAL OF MEDICAL GENETICS (2007)
Strategies to enhance epidermal growth factor inhibition: Targeting the mevalonate pathway
Jim Dimitroulakos et al.
CLINICAL CANCER RESEARCH (2006)
Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling
UK Khanzada et al.
ONCOGENE (2006)
Farnesyl transferase inhibitors
AD Basso et al.
JOURNAL OF LIPID RESEARCH (2006)
Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity
H Harada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Apoptosis in the airways - Another balancing act in the epithelial program
MP O'Sullivan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim
R Ley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activation of ERK1/2 by ΔRaf-1 : ER* represses bim expression independently of the JNK or PI3K pathways
CR Weston et al.
ONCOGENE (2003)
The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells
NWCJ van de Donk et al.
LEUKEMIA (2002)
Protection of human endothelial cells from oxidative stress -: Role of Ras-ERK1/2 signaling
G Cuda et al.
CIRCULATION (2002)
Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines:: an in vitro study
C Denoyelle et al.
CARCINOGENESIS (2001)
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
S Kawata et al.
BRITISH JOURNAL OF CANCER (2001)
Mammalian MAP kinase signalling cascades
LF Chang et al.
NATURE (2001)
Share Paper
